SCHEMBL5281392

SCHEMBL5281392

O=C(Oc1c(F)c(F)c(F)c(F)c1F)c1cnc2ccccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.56
CHRNB2 P17787 1/20 0.47
CHRNA7 P36544 1/20 0.47
CHRNA4 P43681 1/20 0.47
CFTR P13569 1/20 0.46
MAP4K4 O95819 1/20 0.44
CSNK1G2 P78368 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
MAP4K5 Q9Y4K4 1/20 0.44
ALOX15 P16050 1/20 0.43
HTT P42858 1/20 0.43
BCAT1 P54687 1/20 0.43
TOP2A P11388 1/20 0.43
TOP2B Q02880 1/20 0.43
PPARA Q07869 1/20 0.43
KDM4E B2RXH2 3/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HPGDS O60760 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5284239 0.82 HTT (0.68) ALOX15HTTBCAT1KMT2ASMN1; SMN2
SCHEMBL27783091 0.82 MGAM (0.55) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL29281919 0.82 MGAM (0.67) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL29505143 0.80 ALOX15 (0.65) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL2031896 0.80 ALOX15 (0.65) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL27790824 0.80 MGAM (0.65) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL9715583 0.80 MGAM (0.69) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL27259572 0.78 MGAM (0.58) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL28862046 0.77 MGAM (0.65) MGAMCHRNB2CHRNA7CHRNA4CFTR
SCHEMBL31232924 0.77 CES2 (0.52) ALOX15KDM4EKMT2ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 MGAM 488/4885CHRNB2 3225/4885CHRNA7 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.